135 related articles for article (PubMed ID: 9439842)
1. Trigeminal ganglion elicited increases in nucleus trigeminal caudalis blood flow: a novel migraine model.
McCall RB
Brain Res; 1997 Nov; 775(1-2):189-92. PubMed ID: 9439842
[TBL] [Abstract][Full Text] [Related]
2. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Hoskin KL; Goadsby PJ
Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
[TBL] [Abstract][Full Text] [Related]
3. Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Csillik AE; Chadaide Z; Mihály A; Vécsei L
Eur J Neurosci; 2000 Nov; 12(11):3991-4002. PubMed ID: 11069595
[TBL] [Abstract][Full Text] [Related]
4. Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation.
Lambert G; Michalicek J
Eur J Pharmacol; 1996 Sep; 311(2-3):141-51. PubMed ID: 8891594
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?
Goadsby PJ; Hoskin KL
Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929
[TBL] [Abstract][Full Text] [Related]
6. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
Goadsby PJ; Edvinsson L
Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188
[TBL] [Abstract][Full Text] [Related]
7. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
Goadsby PJ; Hoskin KL
Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
[TBL] [Abstract][Full Text] [Related]
8. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
Buzzi MG; Moskowitz MA
Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
[TBL] [Abstract][Full Text] [Related]
9. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633.
McCall RB; Huff R; Chio CL; TenBrink R; Bergh CL; Ennis MD; Ghazal NB; Hoffman RL; Meisheri K; Higdon NR; Hall E
Cephalalgia; 2002 Dec; 22(10):799-806. PubMed ID: 12485205
[TBL] [Abstract][Full Text] [Related]
11. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.
Hoskin KL; Kaube H; Goadsby PJ
Brain; 1996 Oct; 119 ( Pt 5)():1419-28. PubMed ID: 8931567
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
Goadsby PJ; Knight Y
Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
[TBL] [Abstract][Full Text] [Related]
13. The anti-migraine agent sumatriptan induces a calcium-dependent discharge in meningeal sensory neurons.
Strassman AM; Levy D
Neuroreport; 2004 Jun; 15(9):1409-12. PubMed ID: 15194863
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
15. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
Storer RJ; Goadsby PJ
Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
[TBL] [Abstract][Full Text] [Related]
16. Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.
Raval P; Bingham S; Aiyar N; Elliott JD; Hunter AJ; Ohlstein EH; Parsons AA
Br J Pharmacol; 1999 Jan; 126(2):485-93. PubMed ID: 10077242
[TBL] [Abstract][Full Text] [Related]
17. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
[TBL] [Abstract][Full Text] [Related]
18. Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen.
Vause CV; Durham PL
Headache; 2012 Jan; 52(1):80-9. PubMed ID: 22150557
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of Fos-like immunoreactivity in the trigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pig.
Clayton JS; Gaskin PJ; Beattie DT
Brain Res; 1997 Nov; 775(1-2):74-80. PubMed ID: 9439830
[TBL] [Abstract][Full Text] [Related]
20. Functional profile of almotriptan in animal models predictive of antimigraine activity.
Gras J; Bou J; Llenas J; Fernández AG; Palacios JM
Eur J Pharmacol; 2000 Dec; 410(1):43-51. PubMed ID: 11134655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
